ResMed (RMD) Surpasses Q4 Earnings and Revenue Estimates

分组1 - ResMed reported quarterly earnings of $2.55 per share, exceeding the Zacks Consensus Estimate of $2.46 per share, and up from $2.08 per share a year ago, representing an earnings surprise of +3.66% [1] - The company achieved revenues of $1.35 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 1.87%, compared to $1.22 billion in the same quarter last year [2] - ResMed has consistently outperformed consensus EPS and revenue estimates over the last four quarters [2] 分组2 - The stock has gained approximately 21.3% since the beginning of the year, significantly outperforming the S&P 500's gain of 8.2% [3] - The current consensus EPS estimate for the upcoming quarter is $2.49 on revenues of $1.32 billion, and for the current fiscal year, it is $10.46 on revenues of $5.52 billion [7] - The Zacks Industry Rank indicates that the Medical - Products sector is currently in the bottom 26% of over 250 Zacks industries, which may impact stock performance [8]